Neurology Unit, Teaching Hospital Kandy, Kandy, Sri Lanka.
University of Peradeniya, Peradeniya, Sri Lanka.
BMC Neurol. 2021 Apr 24;21(1):176. doi: 10.1186/s12883-021-02203-x.
Migraine is a primary headache disorder and is the most common disabling primary headache disorder that occurs in children and adolescents. A recent study showed that paranasal air suction can provide relief to migraine headache. However, in order to get the maximum benefit out of it, an easy to use effective air sucker should be available. Aiming to fulfil the above requirement, a randomized, double blind control clinical trial was conducted to investigate the efficacy of a recently developed low-pressure portable air sucker.
Eighty-six Sri Lankan school children of age 16-19 years with migraine were enrolled for the study. They were randomly allocated into two groups, and one group was subjected to six intermittent ten-second paranasal air suctions using the portable air sucker for 120 s. The other group was subjected to placebo air suction (no paranasal air suction). The effect of suction using portable air sucker was the primary objective but side of headache, type of headache, and gender were also studied as source variables. The primary response studied was severity of headache. In addition, left and right supraorbital tenderness, photophobia, phonophobia, numbness over the face and scalp, nausea and generalized tiredness/weakness of the body were studied. The measurements on all those variables were made before and after suction, and the statistical analysis was performed based on before and after differences. As a follow-up, patients were monitored for 24-h period.
There was a significant reduction in the severity of headache pain (OR = 25.98, P < 0.0001), which was the primary outcome variable, and other migraine symptoms studied, tenderness (left) (OR = 289.69, P < 0.0001), tenderness (right) (OR > 267.17, P < 0.0001), photophobia (OR = 2115.6, P < 0.0001), phonophobia (OR > 12.62, P < 0.0001) nausea (OR > 515.59, P < 0.0001) and weakness (OR = 549.06, P < 0.0001) except for numbness (OR = 0.747, P = 0.67) in the treatment group compared to the control group 2 min after the suction. These symptoms did not recur within 24-h period and there were no significant side effects recorded during the 24-h observation period.
This pilot study showed that low-pressure portable air sucker is effective in paranasal air suction, and suction for 120 s using the sucker can provide an immediate relief which can last for more than 24-h period without any side effects.
Clinical Trial Government Identification Number - 1548/2016. Ethical Clearance Granted Institute - Medical Research Institute, Colombo, Sri Lanka (No 38/2016). Sri Lanka Clinical Trial Registration No: SLCTR/2017/018 . Date of registration = 29/ 06/2017. Approval Granting Organization to use the device in the clinical trial- National Medicines Regulatory Authority Sri Lanka (16 Jan 2018), The device won award at Geneva international inventers exhibition in 2016 and President award in 2018 in Sri Lanka. It is a patented device in Sri Lanka and patent number was SLKP/1/18295. All methods were carried out in accordance with CONSORT 2010 guidelines.
偏头痛是一种原发性头痛障碍,是儿童和青少年最常见的致残性原发性头痛障碍。最近的一项研究表明,鼻窦空气抽吸可以缓解偏头痛。然而,为了最大限度地受益,应该有一种易于使用且有效的空气抽吸器。为了满足上述要求,进行了一项随机、双盲对照临床试验,以研究最近开发的低压便携式空气抽吸器的疗效。
86 名年龄在 16-19 岁的斯里兰卡在校儿童患有偏头痛,他们被纳入研究。他们被随机分为两组,一组接受六次间歇性十秒钟的鼻窦空气抽吸,使用便携式空气抽吸器抽吸 120 秒。另一组接受安慰剂空气抽吸(无鼻窦空气抽吸)。使用便携式空气抽吸器的效果是主要的观察目标,但头痛的侧别、头痛的类型和性别也作为源变量进行了研究。主要的反应研究是头痛的严重程度。此外,还研究了左、右眶上压痛、畏光、畏声、面部和头皮麻木、恶心和全身疲劳/无力。所有这些变量的测量值在抽吸前后进行,基于前后差异进行了统计分析。作为随访,对患者进行了 24 小时监测。
头痛疼痛严重程度(OR=25.98,P<0.0001)显著降低,这是主要的观察结果,其他研究的偏头痛症状,如压痛(左)(OR=289.69,P<0.0001)、压痛(右)(OR>267.17,P<0.0001)、畏光(OR=2115.6,P<0.0001)、畏声(OR>12.62,P<0.0001)、恶心(OR>515.59,P<0.0001)和乏力(OR=549.06,P<0.0001),除了麻木(OR=0.747,P=0.67),在治疗组中,与对照组相比,在抽吸后 2 分钟内有明显的改善。这些症状在 24 小时内没有复发,在 24 小时观察期间没有记录到任何明显的副作用。
这项初步研究表明,低压便携式空气抽吸器在鼻窦空气抽吸中是有效的,使用抽吸器抽吸 120 秒可以立即缓解头痛,缓解效果可持续超过 24 小时,且无副作用。
临床研究政府识别号-1548/2016。伦理批准机构-科伦坡医学研究所,斯里兰卡(编号 38/2016)。斯里兰卡临床试验注册号:SLCTR/2017/018。登记日期=2017 年 6 月 29 日。批准在临床试验中使用该设备的机构-斯里兰卡国家药品监管局(2018 年 1 月 16 日),该设备于 2016 年在日内瓦国际发明者展览会上获奖,并于 2018 年在斯里兰卡获得总统奖。它是斯里兰卡的专利设备,专利号为 SLKP/1/18295。所有方法均按照 CONSORT 2010 指南进行。